FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Heat wave cancels some DC Independence Day celebrations

Two Americas: Mamdani and Trump give speeches ahead of Independence Day

Here Are 5 Insane Books Elementary Schools Are Offering Kids

The Answer To America’s Food Security Woes

Trump pardons 9 people convicted of tampering with emission controls on diesel engines

Pope Leo urges US to welcome immigrants in America 250 speech before visiting global migrant hotspot

OpenAI’s Sam Altman wants to negotiate a 5% stake in company for US if competitors agree to key provision

Iran begins Khamenei’s funeral 126 days after assassination

July 1776 Copy of Declaration of Independence Discovered Outside US in Foreign Navy Captain’s Papers

WATCH – Charlie Kirk’s Final July 4 Message: ‘Why America Is a Christian Nation’

NC governor faces criticism for skipping Trump-backed America 250 event

Trump’s Mount Rushmore address features 28 minutes of iconic words, 23 minutes of dazzling light, fireworks

Thune and Trump share friendly greeting after critical clashes

CEO’s fire death sparks mystery, will fight over tech titan’s fortune

Top Trump official touts how DC makeover is proof America is rejecting ‘decline by choice’

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”